BioLife Solutions, Inc. Deferred Tax Assets, Investment in Subsidiaries
BioLife Solutions, Inc. (BLFS) had Deferred Tax Assets, Investment in Subsidiaries of $0 as of 2016-12-31, per its 10-K filed 2017-03-15.
Discontinued › Notes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsInvestmentInSubsidiaries · last filed 2017-03-15
- 2016-12-31: Deferred Tax Assets, Investment in Subsidiaries $0.00.
- 2015-12-31: Deferred Tax Assets, Investment in Subsidiaries $246.24K.
- 2014-12-31: Deferred Tax Assets, Investment in Subsidiaries $0.00.
| Period end | Deferred Tax Assets, Investment in Subsidiaries |
|---|---|
| 2016-12-31 | $0.00 10-K · filed 2017-03-15 |
| 2015-12-31 | $246.24K 10-K · filed 2017-03-15 |
| 2014-12-31 | $0.00 10-K · filed 2016-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B |